Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
You might also be interested in these items
100 Cases in Clinical Medicine, 3e
100 Cases in Emergency Medicine and Critical Care
100 Cases in Medical Data Interpretation
100 Cases in Orthopaedics and Rheumatology
Sign up for our newsletter
Sign up for our mailing list to receive new product alerts, special offers, and coupon codes.